Iboga

Observational Study

April 12, 2020

Ibogaine Treatment Outcomes for Opioid Dependence From a Twelve-Month Follow-up Observational Study

By Geoffrey. E. Noller et al.

Research Article

June 5, 2018

Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes

By Deborah. C. Mash et al.

Article

May 14, 2021

What to Know About Ibogaine Treatment for Addiction

By Jennifer Huizen

Article

May 2, 2023

Psychedelic Inspires New Treatments for Addiction and Depression

By Levi Gadye

Article

April 5, 2021

Inside Ibogaine, One of the Most Promising and Perilous Psychedelics for Addiction

By Mandy Oaklander

Research Article

October 17, 2017

Subjective Effectiveness of Ibogaine Treatment for Problematic Opioid Consumption: Short- and Long-Term Outcomes and Current Psychological Functioning

By Alan K. Davis et al.

Article

January 24, 2023

The Psychedelic Ibogaine Can Treat Addiction. The Race is on to Cash In

By Kaitlin Sullivan et al.

Research Article

January 29th, 2015

The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation

By Xaver Koenig et al.

Editorial

June 24, 2021

Evaluating the Toxicity and Therapeutic Potential of Ibogaine in the Treatment of Chronic Opioid Abuse

By Matthias Luz et al.

Research Article

2002

The IBOGA alkaloids and their role as precursors of anti-neoplastic bisindole catharanthus alkaloids

By Richard J. Sundberg et al.

Journal Review

January 28, 2022

The Iboga Enigma: The Chemistry and Neuropharmacology of Iboga Alkaloids and Related Analogs

By Rishab N. Iyer et al.

Journal Article

January 2022

New iboga-type alkaloids from Ervatamia officinalis and their anti-inflammatory activity

By Ben-gin Tang et al.